2014 ACKC Campaign for Research Funding

April 24th, 2013 by Staff

ACKC is initiating its annual campaign to get a $15 million appropriation for kidney cancer research as part of the Congressionally Directed Medical Research Programs of the Department of Defense. The Dear Colleague Letter is signed by Senator Charles Schumer (D-NY) and Representative Peter King (R-NY) and Representative Carolyn McCarthy (D-NY).

To send an automated letter to your senators and representative asking them to support this essential research funding, click here: Send a Letter.

To see accomplishments of previous years’ campaigns, click Awards.

Read More

2013 ACKC Campaign for Research Funding

April 24th, 2013 by Staff

Annual campaign to get a $15 million appropriation for kidney cancer research Campaign 2013

Read More

Our New Patient Guide is Here

November 14th, 2012 by Sara Mears

ACKC is pleased to announce the
publication of “Managing My Cancer,”
the second of four patient guides.
Learn more >

Read More

GlaxoSmithKline announced today, 10/11/2012, that they will make all clinical trial data available to researchers in their effort to become a more transparent company. This move could have a positive effect on clinical oncology practice.

Read More

A look at IL-15 and IL-2

April 25th, 2012 by Chris Battle, survivor

IL-15 is a cousin of IL-2, but it is believed to be more targeted than the latter. Both drugs are immunotherapeutic,attempting to kickstart the body’s natural immune system into fighting the cancer naturally. Each tries to increase and activate lymphocyites which house Natural Kill Cells. I’m not making this up; Natural Killer Cellsis actually what they are called. And although they sound like murderous psychotics, and to some degree they are, they are on our side. Like the body’s own mob hit men.

Read More